LPL Financial LLC Grows Holdings in Doximity, Inc. (NASDAQ:DOCS)

LPL Financial LLC increased its stake in Doximity, Inc. (NASDAQ:DOCS) by 5.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 75,757 shares of the company’s stock after buying an additional 3,967 shares during the period. LPL Financial LLC’s holdings in Doximity were worth $4,045,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Handelsbanken Fonder AB grew its position in shares of Doximity by 0.7% during the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock worth $1,586,000 after buying an additional 200 shares in the last quarter. UMB Bank n.a. increased its position in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the period. Fielder Capital Group LLC lifted its position in shares of Doximity by 4.5% in the 4th quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock worth $293,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC increased its holdings in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after buying an additional 250 shares during the period. Finally, GAMMA Investing LLC increased its holdings in Doximity by 20.6% during the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock valued at $93,000 after buying an additional 296 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Price Performance

Shares of Doximity stock opened at $51.52 on Friday. The stock has a market cap of $9.62 billion, a PE ratio of 51.52, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The firm has a fifty day moving average price of $64.86 and a 200 day moving average price of $55.41. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21.

Analysts Set New Price Targets

DOCS has been the topic of a number of analyst reports. Raymond James reiterated an “outperform” rating and issued a $83.00 price target (up from $65.00) on shares of Doximity in a report on Friday, February 7th. Needham & Company LLC raised their price target on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 7th. The Goldman Sachs Group boosted their price objective on shares of Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. KeyCorp reduced their price target on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. Finally, Bank of America upped their target price on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Eleven research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $64.72.

Insider Buying and Selling at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 37.40% of the company’s stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.